Amyris, Genome Compiler Collaborate
News Aug 17, 2015
The two companies announced a collaboration agreement in March 2015 to integrate Amyris’s automated lab services with Genome Compiler’s online design tools and e-commerce platform to enable users to design and order DNA or other biological products seamlessly.
Researchers Can Achieve More – In Less Time at Lower Cost
Through the integrated platform, researchers can leverage a comprehensive solution from design to delivery that represents a first-of-its-kind integrated DNA design and construction service. The service allows for greater levels of automation, enabling faster progress, and will be less expensive and more sophisticated than other available offerings. Prospective customers will have access to Genome Compiler’s advanced software tools, along with Amyris’s extensive libraries of verified genetic parts, DNA construction and editing methods, all derived from its expertise in innovative bioscience technology.
“Amyris’s leadership role in bioscience technology has enabled us to secure legacy expertise in DNA construction research and automation to speed development and reduce costs,” said Joel Cherry, President of Research & Development at Amryis. “Today, we are able to open up key aspects of our DNA design and construction platform services, technical aptitude and knowledge base in synch with Genome Compiler’s powerful software tools to provide a fully integrated platform for companies and others seeking to pursue synthetic biology solutions.”
“We’re pleased to announce the availability of this testing program with Amyris so quickly after announcing our partnership,” said Omri Amirav Drory, CEO of Genome Compiler. “We have been working closely with Amyris in recent months and are excited by what we have achieved in creating a truly integrated genomic research platform providing a unique outsourced solution for any organization’s synthetic biology development needs along with the ability to achieve significant time and cost savings.”
This joint project between Amyris and Genome Compiler has been funded in part by a grant from the Binational Industrial Research and Development Foundation (BIRD Foundation), a U.S.-Israeli partnership between private sectors to expand private high-tech industries.
Bioethics Council Rules Heritable Genome Editing "Ethically Acceptable" In Certain CircumstancesNews
A leading UK bioethics advisory body has weighed in on the debate around human genetic modification, concluding that heritable genome editing – modifying the DNA of an egg, sperm or embryo with changes that will be passed on to future generations – could be ‘morally permissible’ in humans, provided key ethical tests are met.
Genetic Factors Leading to Rare Bone Fusion Disorder IdentifiedNews
Genome sequencing establishes multiple genes responsible for a rare condition that cause bone fusionREAD MORE
Getting to Know the Microbes that Drive Climate ChangeNews
A new understanding of the microbes and viruses in the thawing permafrost in Sweden may help scientists better predict the pace of climate change.READ MORE